ImVitro Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 9

ImVitro General Information

Description

Developer of AI-based IVF decision-making tools designed to tackle infertility. The company uses deep learning algorithms to analyze a myriad of clinical inputs to detect hidden patterns and predict the embryo with the highest chance of implantation, enabling IVF clinics to minimize the number of cycles patients have to go through to become parents and maximize their output.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • TechCare 130 rue Lourmel
  • Saint Denis
  • 75015 Paris
  • France
+33 09
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Decision/Risk Analysis
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, FemTech, HealthTech, Life Sciences
Corporate Office
  • TechCare 130 rue Lourmel
  • Saint Denis
  • 75015 Paris
  • France
+33 09

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImVitro Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 05-Dec-2022 $2.5M Completed Generating Revenue
4. Seed Round 11-Jun-2020 Completed Generating Revenue
3. Grant 10-Feb-2020 Completed Generating Revenue
2. Accelerator/Incubator 15-Dec-2019 $98.7K Completed Startup
1. Accelerator/Incubator 24-Sep-2019 $98.7K $98.7K Completed Startup
To view ImVitro’s complete valuation and funding history, request access »

ImVitro Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view ImVitro’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ImVitro Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of AI-based IVF decision-making tools designed to tackle infertility. The company uses deep learning algorithm
Enterprise Systems (Healthcare)
Paris, France
22 As of 2024

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImVitro Competitors (1)

One of ImVitro’s competitors is Future Fertility, a Venture Capital-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Future Fertility Venture Capital-Backed Toronto, Canada
You’re viewing 1 of 1 competitors. Get the full list »

ImVitro Patents

ImVitro Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3951793-A1 Devices and processes for machine learning prediction of in-vitro fertilization Inactive 07-Aug-2020

ImVitro Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImVitro Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Compound (New York) Venture Capital Minority
LDV Capital Venture Capital Minority
MMC Ventures Venture Capital Minority
Tiny Supercomputer Investment Company Venture Capital Minority
Fly Ventures Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

ImVitro FAQs

  • When was ImVitro founded?

    ImVitro was founded in 2019.

  • Where is ImVitro headquartered?

    ImVitro is headquartered in Paris, France.

  • What is the size of ImVitro?

    ImVitro has 22 total employees.

  • What industry is ImVitro in?

    ImVitro’s primary industry is Enterprise Systems (Healthcare).

  • Is ImVitro a private or public company?

    ImVitro is a Private company.

  • What is ImVitro’s current revenue?

    The current revenue for ImVitro is .

  • How much funding has ImVitro raised over time?

    ImVitro has raised $4.03M.

  • Who are ImVitro’s investors?

    Compound (New York), LDV Capital, MMC Ventures, Tiny Supercomputer Investment Company, and Fly Ventures are 5 of 9 investors who have invested in ImVitro.

  • Who are ImVitro’s competitors?

    Future Fertility is a competitor of ImVitro.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »